lobbying_activities: 2286540
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2286540 | d7770ffc-e2ff-418d-9434-8d570c4c7f56 | Q1 | JOHNSON & JOHNSON SERVICES, INC. | 20686 | JOHNSON & JOHNSON SERVICES INC | 2019 | first_quarter | HCR | - H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - H.R. 269 - Pandemic and All-Hazards Preparedness & Advancing Innovation Act of 2019, regarding all provisions - Issues related to the reputation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to the medical device tax repeal - Issues related to medical product communications - Issues related to medical product review - Issues related to talc safety - Issues related to drug pricing reform - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 1440000 | 0 | 0 | 2019-04-22T14:26:16.577000-04:00 |